Stocks:
5,169
ETFs:
2,288
Exchanges:
11
Market Cap:
$65.09T
24h Vol:
$8.59B
Dominance:
MSFT:4.90%
Stocklytics Platform
Asset logo for symbol ACB
Aurora Cannabis
ACB
73
$5.74arrow_drop_down2.71%-$0.16
High Growth

Performance History

Chart placeholder
Key Stats
Open$5.82
Prev. Close$5.90
EPS-57.71
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$336.50M
PE Ratio-
LOWHIGH
Day Range5.70
5.88
52 Week Range2.84
11.50
Ratios
P/B Ratio0.95
Revenue$233.29M
Operating M. %-24.07%
Earnings$0.00
Earnings Growth %84.56%
EBITDA Margin %-14.29%
ROE %-137.28%
EPS-57.71

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

info
There's no data available for Analyst Forecast

Analyst Ratings

info
There's no data available for Analyst Ratings

Correlated Companies

PRICE$878.45
24H (%)arrow_drop_down0.55%
24H ($)-$4.88
MARKET CAP$771.28B
PRICE$497.12
24H (%)arrow_drop_down0.03%
24H ($)-$0.17
MARKET CAP$443.63B
PRICE$145.53
24H (%)arrow_drop_up0.06%
24H ($)$0.09
MARKET CAP$347.62B
PRICE$129.48
24H (%)arrow_drop_up0.08%
24H ($)$0.11
MARKET CAP$318.88B

About Aurora Cannabis (ACB)

Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, the Caribbean, South America, and Israel; supply of propagated vegetables and ornamental plants in North America; and distribution and sale of hemp-derived cannabidiol (CBD) products. In addition, the company cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts; and provides dried flowers, vapes, dried milled strains, strain-specific extracts, strain specific cannabis oils, and concentrates. Further, it offers recreational cannabis products, such as flowers, vapes, ingestibles, concentrates, extracts, and CBD products; and patient counseling and outreach services. The company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. Aurora Cannabis Inc. is headquartered in Leduc, Canada.

Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
CEO
Mr. Miguel Martin
Headquarters
Leduc
Employees
1338
Exchange
NASDAQ
add Aurora Cannabis  to watchlist

Keep an eye on Aurora Cannabis

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help
What is Aurora Cannabis 's (ACB) price per share?

The current price per share for Aurora Cannabis (ACB) is $5.74. The stock has seen a price change of -$0.16 recently, indicating a -2.71% change. This reflects the stock's recent market performance and investor sentiment.

help
What is the 52-week high and low for Aurora Cannabis (ACB)?

For Aurora Cannabis (ACB), the 52-week high is $11.5, which is 100.35% from the current price. The 52-week low is $2.84, the current price is 102.11% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help
Is Aurora Cannabis (ACB) a growth stock?

Aurora Cannabis (ACB) has shown an average price growth of 0.41% over the past three years. It has received a score of 98 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Aurora Cannabis as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help
What is Aurora Cannabis (ACB) stock price performance year to date (YTD)?

As of the latest data, Aurora Cannabis (ACB) has a year-to-date price change of 20.89%. Over the past month, the stock has experienced a price change of -19.38%. Over the last three months, the change has been 80.5%. Over the past six months, the figure is 19.58%. Looking at a longer horizon, the five-year price change stands at -99.37%.

help
Is Aurora Cannabis (ACB) a profitable company?

Aurora Cannabis (ACB) has a net income of -$265.33M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -24.07% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $233.29M, with a revenue growth rate of 5.4%, providing insight into the company's sales performance and growth. Operating income is noted at -$254.32M. Furthermore, the EBITDA is -$24.4M.

help
What is the market capitalization of Aurora Cannabis (ACB)?

Aurora Cannabis (ACB) has a market capitalization of $336.51M. The average daily trading volume is 1.07M, indicating the stock's liquidity and investor engagement.

News

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level